Tandem Diabetes Care, Inc.’s Control-IQ+ Technology, used with the t:slim and Mobi insulin pumps, becomes the second AID algorithm technology approval in the United States for people with type 2 ...

Medtronic has secured a new approval in Europe, greatly expanding the reach of its MiniMed 780G pump system—including for ...

The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people with insulin-treated type 2 diabetes (T2D), a new randomized trial showed.

The estimated rates of severe or clinically significant hypoglycemia were 0.26 events and 2.18 events per patient-year of exposure for IcoSema and insulin glargine/insulin aspart, respectively.

Aug. 27, 2024 – People with type 2 diabetes can now wear a device that will automatically deliver doses of insulin, following an expanded approval by the FDA on Monday.. Called the Omnipod 5, it ...

More information: Yogish C. Kudva et al, A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes, New England Journal of Medicine (2025). DOI: 10.1056/NEJMoa2415948 ...

Medically reviewed by Lindsay Cook, PharmD Type 2 diabetes is a form of diabetes characterized by high blood sugar (glucose), insulin resistance, and a decrease in insulin production. For some ...

In QWINT-3, 986 adults with type 2 diabetes who were using basal insulin and up to three glucose-lowering drugs at baseline without prandial insulin were enrolled (median age, 62 years; 44% women).

New research offers an alternative to daily insulin shots for the 8 million people in the United States with type 2 diabetes. Eli Lilly’s once-weekly insulin injection is just as effective as ...

Inhaled insulin is effective for controlling blood sugar levels in children with diabetes, providing them with a ...

With Type 1 diabetes, your body can’t produce enough insulin and with Type 2 diabetes, it doesn’t use it properly. But even beyond the two types, the effects and treatment associated with ...

The FDA has cleared its first automated insulin pump for adults with Type 2 diabetes, with Insulet’s Omnipod 5 delivery system opening the door to a population of more than 6 million people.